Search Results
Results found for "medicinal chemistry"
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
Personalised Medicine Another significant application of these findings is in personalised  medicine In summary, the findings of this study have significant implications for drug design, personalised medicine
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
With street-level contamination rising faster than medicine can adapt, Catherine’s work shows why overdose The insight is simple but urgent: the drug supply evolves faster than medicine.  And the illicit supply is moving faster than clinical medicine can adjust.
- Innovative Data-Driven Solutions: The pHSense Revolution
It was the result of chemistry, collaboration, and relentless effort until the signal finally confirmed The Chemistry That Almost Didn’t Work Designing pH-sensitive rare-earth complexes was not an obvious The chemistry involved is notoriously complex. Solubility poses significant challenges. The chemistry originated from Parker’s lab. What started as a chemistry problem has evolved into a discovery platform.
- From Failed Experiments to Predictive GPCR Models
Collaborating with chemists, biologists, and pharmacologists not only made his predictions more useful Today, his group includes around ten computational chemists and one in-house medicinal chemist. This is when the synthetic expertise of the chemist becomes essential. Carlsson notes that it’s easier to find pharmacologists to run assays than it is to persuade chemists
- Posttranslational modifications in GPCR internalization
receptor internalization, the mechanism of physiology/pathology and novel drug targets for precision medicine offer new insights into the regulatory mechanism of GPCR signaling and novel drug targets for precision medicine
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
2021 Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) "SAN CARLOS, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending
- Michel Bouvier appointed Knight of the Ordre national du Québec
Molecular Pharmacology Research Unit and Professor in the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine of the Université de Montréal, is appointed Knight of the Ordre national
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
of Discovery pHSense wasn’t built in a vacuum—it was born from decades of groundwork in rare earth chemistry It’s the product of layered collaborations—with Durham University chemist David Parker on the probe chemistry
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Kenakin acknowledges the increasing utility of in silico alerts in early decision-making, arming medicinal chemists and project leaders with tools to preempt costly wet-lab dead ends.
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
Maria Majellaro Celtarys specializes in the custom development of fluorescent ligands  using a modular chemistry But what sets them apart isn’t just chemistry. It’s empathy.
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
He went on to study medicine at the Royal College of Surgeons in Ireland before receiving his Medical Degree from Temple University – Lewis Katz School of Medicine.
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Later, exposure to veterinarians working in agricultural settings inspired him to train in veterinary medicine Enter a long-term collaboration with chemist Dr.
- Trevena Reports Second Quarter 2022 Results and Provides Business Update
Nasdaq:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines
- First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity
Signaling Terry Kenakin, Ph.D., Professor of Pharmacology at the University of North Carolina School of Medicine
- Naggie and Rajagopal Elected Members of American Society for Clinical Investigation
March 2022 "March 3, 2022 Susanna Naggie, MD, and Sudarshan Rajagopal, MD, PhD Two School of Medicine
- Why GPCR Biologic Drugs Stabilize Active States Small Molecules Struggle to Reach
Not because small-molecule chemistry is weaker, but because a small molecule, by definition, occupies It is that allosteric chemistry has a structural advantage when the goal is stabilizing an active state small-molecule agonist program encounters at a family B GPCR may be a feature of the geometry, not a flaw in the chemistry
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
That’s where computational chemistry steps in. This case study highlights why computational chemistry is no longer a side tool—it’s a driver of discovery
- Molecular creativity in drug discovery
delivers this week: a deep dive into molecular creativity, rational design, and the overlooked role of chemistry Terry’s Corner: Why Chemistry Still Rules For decades, discovery focused on targets. Terry Kenakin reveals how drug chemistry defines function, not just fit.
- ShouTi Pharma has a brand new website
innovative, global team on a bold mission to improve health by creating and developing life-changing medicines
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
Belgium, has been named the winner of Brandeis’ 24th Jacob and Louise Gabbay Award in Biotechnology and Medicine
- Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist
2022 "By Cliona MacSweeney | Apr 20, 2022 Cliona MacSweeney, a project director in our Translational Medicine
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
“The desire to take medicine is perhaps the greatest feature which distinguishes man from animals.” Current Chemical Genomics and Translational Medicine, 7, 9. Kenakin, T. (2019).
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines
- Adenosine receptor signalling in Alzheimer's disease
Although there are no available medicines targeting these receptors approved for treating dementia, we
- Pharmacology Isn't What You Think—It's So Much More
You’ll uncover: Why pharmacology is the glue between chemistry and biology How to interpret drug behavior
- Adenosine receptor signalling in Alzheimer's disease
Although there are no available medicines targeting these receptors approved for treating dementia, we
- Exscientia is 10 years old this July!
the first-ever AI-designed drug candidates to enter clinical trials, the first AI-driven precision medicine
















